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analysis was used to examine characteristics associated with
support for tobacco and alcohol price increases.
Results
Support for price increases on beer varied from 8% in Georgia
and Armenia to around 30% in Kyrgyzstan, Azerbaijan and
Russia, and support for price increases on spirits ranged from
11% in Armenia to around 40% in Kyrgyzstan and Moldova.
Support for price increases on tobacco varied from 38% in
Georgia to around 70% in Belarus and Moldova. Common
characteristics associated with supporting price increases on
alcohol and tobacco included higher levels of education, good
household situation, being a former or never smoker, low
alcohol consumption, and knowledge on the harmful health
effects of tobacco and alcohol use.
Conclusions
This study provides evidence of public support for alcohol and
particularly tobacco price increases in the study countries.
Policy makers seeking to tackle harmful drinking and tobacco
use through price mechanisms may have more support than
they realise and should seek to develop and capitalise on such
support.
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Majority of households (82.2%) in Armenia had at least one
smoker and about 70.0% had no smoking restrictions in their
homes in 2007. This clinical trial aimed to develop and test a
novel approach for educating non-smoking mothers and
smoking family members on dangers of SHS and provide a
feasible approach to promote smoke-free home policies in
Yerevan, Armenia.
Methods
Households with 2–6 year-old children daily exposed to SHS at
home were selected by multistage random sampling and
randomized into intervention and control groups. The
intervention included a counseling session, distribution of a
tailored educational brochure, demonstration of home air
pollution by SidePak-assisted measurement of particulate
matter 2.5, and two follow-up counseling calls. The control
group received only a brief educational leaflet. The research
team used environmental measurements (airborne nicotine
monitors), biomarkers (hair samples from children) and
surveys (non-smoking mothers and smoking family members)
to identify SHS exposure and explore knowledge about SHS
health hazards at baseline and four months follow-up. The
study used paired t-test and logistic regression for data
analysis.
Results
250 households were enrolled and 224 completed the study.
The mothers’ survey suggested that the change in knowledge
score was significantly higher in the intervention group
compared to controls (1.8 vs. 0.7, p < 0.05). At baseline and
follow-up the mothers’ knowledge was higher than that of
smokers from the same household (p < 0.001). More house-
holds from the intervention group compared to controls
reported having restricted indoor smoking at follow-up
(23.3% vs. 18.6%; OR = 1.3, p = 0.34) and decreased children’s
SHS exposure from daily to less than daily (20.0% vs. 12.2%;
OR = 1.8, p = 0.10).
Conclusions
Educational programs that directly or indirectly (through non-
smoking mothers) target household smokers’ behavior change
may be effective in educating family members about the health
hazards of SHS, promoting smoking restrictions at homes and
ultimately decreasing children’s exposure to SHS. This
intervention model can be tested in other settings, such as
primary health care pediatric offices, to educate and empower
non-smoking mothers to reduce children’s SHS exposure at
homes.
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Background
The World Health Organization, the U.S. Centers for Disease
Control and Prevention, and the Canadian Public Health
Association have developed the Global Health Professions
Student Survey (GHPSS) questionnaire in order to collect data
on tobacco use and cessation counselling among health
profession students.The aims of this study were to examine
smoking prevalence, knowledge, attitudes and behaviours
among medical doctors specializing in Public health
(MDSPH) in Italy, using the GHPSS approach.
Methods
A multicentre cross-sectional study was carried out in 24
Italian Schools of Public Health (n.456 MDSPH) from January
to April 2012. Questionnaires were administered in anon-
ymous, voluntary and self-administered via a special web-site,
created ad hoc for the survey. The questionnaire was composed
of 44 questions, distributed in 6 sections on: tobacco use
prevalence, exposure to environmental tobacco smoke, atti-
tudes, behaviour/cessation, curriculum/ training and demo-
graphic information.
Results
388 Italian MDSPH answered to the questionnaire on the web-
site (85%). 247 (63,7%) were females and 247 (63,7%) were
over 30 year old. 81 MDSPH (20,9%) declared to be smokers.
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Regarding attitudes towards tobacco use, 309 (79,6%)
considered health professionals as behavioural models for
patients, and 375 (96,6%) thought health professionals have a
role in giving advice or information about smoking cessation.
348 (89,7%) of responders had received smoking cessation
training during their medical school years.
Conclusions
Healthcare professionals play a key role in the process of
smoking cessation both as advisers and behavioural models for
the citizens, especially in their role in helping smokers who
wish to quit. Given the high prevalence of smokers among
MDSPH and the key role of these professionals as behavioural
models, our results highlight the importance of focusing
attention on smoking cessation training addressed to medical
doctor specializing in Public Health.
D.4. Workshop: What health research do you
want for Europe?
Chair: Walter Deville´, The Netherlands
Organiser: EUPHA Lead for Research
Public health research in Europe includes health determinants,
health promotion and health services-operating at system and
organisational levels. Health policy and practice should
be evidence-based; and evidence is created through research.
But how is research created? What systems exist, what are
needed? Also, in a global field, there has been an emphasis on
increasing research towards the MDGs.
This Workshop will explore the current position for health
research in two ‘northern’ continents, and EU support towards
the research in other global regions. The format will be panel
presentations by the main speakers, invited interventions from
the floor from representative organisations (including EPHA,
EHMA, ASPHER, IEA) and opportunities for conference
participants for lively questions and discussion on health
research policy.
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Climate change, an ageing population, rising costs of health
and social care systems are some of the challenges Europe has
to address to safeguard the health of its citizens. Incremental
development, based solely on present knowledge, is not
sufficient; new ideas and knowledge must be sought and
implemented. The European Commission s proposed research
agenda ‘Horizon 2020’ seeks to meet these new challenges,
and represents a break from the past. It brings together all
research and innovation funding on EU level into one single
programme. In terms of health research, close collaboration
between academia, industry, healthcare providers and regula-
tory agencies will be needed to meet the challenges. It
inevitably leads to the question whether stronger links and
synergies between national and EU research activities should
be developed, and if so, how? Also, is there a need for a
European strategic public health research agenda?
This presentation will offer a basis for a wider discussion on
policies and programmes for research and innovation in public
health. It focuses on what can be realistically achieved at EU
level and, in connection thereto, how we should proceed.
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CIHR has 13 virtual institutes, networks of researchers
collaborating across sectors, disciplines and regions, giving
support from bio-medical and clinical research to research
on health systems, health services, and health determinants.
In the period 2007–2014, the Institute of Population and
Public Health is supporting four broad research areas-equity,
interventions, implementation, and methodologies. An inter-
national review in 2011 has proposed future-oriented health
concerns such as climate change and chronic diseases in
LMICs, and the need to demonstrate a return on research
investment. Broader approaches require knowledge synthesis,
data platforms, scientific capacity and strategic partnerships
within and outside of the health sector. To raise funding
allocations for health systems sciences relative other areas of
investment, it is also critical to address the mix, mandates and
reporting of peer review committees in open grants competi-
tion. In its coming programme from 2014, IPPH will seek
to fund fewer but larger, more generalisable and scalable
activities, with a focus particularly on interventions.
European support for global health research
Francisco Beccerra
F Beccera1, S Gerstl2
1Council on Health Research for Development, Geneva, Switzerland
2Consultant, Epicentre, MSF-France
The European Commission’s international health research
programme call for 2012 was directed towards health systems
research, seeking consortia of at least 8 partners. The
maximum EU funding for proposals was up to E6 m over 5
years, and total EU budget was E18 m. Of 8 proposals reaching
the second stage, the final selection was for three.
As a case-study, MASCOT, funded by EU’s Health research
call for 2011, addresses the health-related Millennium
Development Goals through support for research on systems
for maternal and child health. There are 11 partners from
3 geographical areas (Europe, Africa and Latin America).
MASCOT will create North-South and South-South links,
and provide evidence for policy advice and practice, map
institutions and research teams, and detect research results,
strategies, programs and policies.
The two-stage process continues to require considerable
investment, with low absolute success. How can better
comparative evidence for health systems research be generated?
Should the research community develop a ‘clearing house’ or
register on existing international collaborative research, so as
better to define needs and strengthen the case for future
funding?
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